Discover how Nevisense can support your clinical workflow

Book a personalized demonstration to learn how Nevisense can complement your current diagnostic process and provide objective support for clinical decision-making.

Follow SciBase on LinkedIn

Stay updated with the latest news and research

SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops
and commercializes Nevisense, a unique point-of-care platform that combines AI and advanced EIS technology to elevate diagnostic
accuracy, ensuring proactive skin health management.

Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.
The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015.

SCIBASE AB (HQ)

Mailing Address
PO Box 3337
103 67 Stockholm Sweden

Visiting Address
Landsvägen 39
172 63 Sundbyberg
Sweden

Phone: +46 8 410 620 00
Fax: +46 8 615 22 24
General Enquiries: info@scibase.com
Orders: order@scibase.com

SCIBASE, GERMANY

SciBase GmbH
C/o Business Sweden
Friedrichstr. 154
101 17 Berlin
Germany

Phone: +49 172 823 3386
(+49 30 893 60 680)
Fax: +49 89 209 31 452
General Enquiries: info@nevisense.de
Orders: order@scibase.com

SCIBASE, US

SciBase Inc,
263 Shuman Blvd., Suite 145,
Naperville, IL 60563 USA
Email: us-sales@scibase.com

INFORMATION

PRIVACY AND COOKIE POLICY
COOKIE SETTINGS